1. India Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Jagsonpal Pharmaceuticals Limited

Jagsonpal Pharmaceuticals Limited

JAGSNPHARM.BO
Jagsonpal Pharmaceuticals LimitedIN flagBombay Stock Exchange
203.65
INR
+1.30
- -
13.67BMarket Cap

Total Valuation

Jagsonpal Pharmaceuticals Limited carries a market capitalization of 13.67B, placing it among publicly traded companies globally. Its enterprise value stands at 11.46B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap13.67B
Enterprise Value11.46B

Share Statistics

Jagsonpal Pharmaceuticals Limited currently has 66.96M shares outstanding.

Shares Outstanding66.96M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Jagsonpal Pharmaceuticals Limited trades at a trailing price-to-earnings ratio of 28.89. The price-to-sales ratio is 4.33, and the price-to-book ratio stands at 92.92.

PE Ratio28.89
PS Ratio4.33
PB Ratio92.92
P/TBV Ratio6.28
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Jagsonpal Pharmaceuticals Limited trades at an EV/EBITDA multiple of 23.57 and an EV/FCF ratio of 1,488.92. The EV/Sales ratio of 3.99 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 23.57 provides insight into valuation relative to core operating earnings.

EV / Sales3.99
EV / EBITDA23.57
EV / EBIT23.57
EV / FCF1,488.92

Financial Position

Jagsonpal Pharmaceuticals Limited maintains a current ratio of 5.06, meaning it holds 5.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 2.96, indicating elevated leverage, while an interest coverage ratio of 47.31 demonstrates strong ability to service its debt obligations.

Current Ratio5.06
Quick Ratio3.75
Debt / Equity2.96
Debt / EBITDA0.17
Interest Coverage47.31

Financial Efficiency

Jagsonpal Pharmaceuticals Limited posts a return on equity of 323.04 and a return on invested capital of 13.66.

Return on Equity (ROE)323.04
Return on Assets (ROA)14.48
Return on Invested Capital (ROIC)13.66
Return on Capital Employed (ROCE)198.98
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover6.99

Taxes

Over the trailing twelve months, Jagsonpal Pharmaceuticals Limited has paid 144.36M in income taxes, reflecting an effective tax rate of 25.10.

Income Tax144.36M
Effective Tax Rate25.10

Stock Price Statistics

Jagsonpal Pharmaceuticals Limited's stock has declined approximately -9.46877% over the past 52 weeks. The 50-day moving average sits at 198.97, while the 200-day moving average is 202.89.

Beta (5Y)N/A
52-Week Price Change-9.46877%
50-Day Moving Average198.97
200-Day Moving Average202.89
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Jagsonpal Pharmaceuticals Limited generated 2.87B in revenue and converted that into 430.82M in net income, yielding earnings per share of 6.28. EBITDA reached 486.30M, while operating income came in at 486.30M.

Revenue2.87B
Gross Profit1.83B
Operating Income486.30M
Pretax Income575.18M
Net Income430.82M
EBITDA486.30M
EBIT486.30M
Earnings Per Share (EPS)6.28

Balance Sheet

Jagsonpal Pharmaceuticals Limited holds 1.06B in cash and equivalents against 81.65M in total debt, resulting in a net debt position of -100.42M. Total book value stands at 133.93M, with working capital of 1.15B providing operational flexibility.

Cash & Cash Equivalents1.06B
Total Debt81.65M
Net Debt-100.42M
Equity (Book Value)133.93M
Book Value Per Share1.98
Working Capital1.15B

Margins

Jagsonpal Pharmaceuticals Limited operates with a gross margin of 63.66, reflecting its pricing power and cost economics. The operating margin of 16.93 and net profit margin of 15.00 provide insight into operational efficiency.

Gross Margin63.66
Operating Margin16.93
Pretax Margin20.03
Profit Margin15.00
EBITDA Margin16.93

Stock Splits

Jagsonpal Pharmaceuticals Limited's most recent stock split took place on July 20, 2004 with a 1:8 split ratio.

Last Split Date7/20/2004
Split Ratio1:8

Scores

Jagsonpal Pharmaceuticals Limited posts an Altman Z-Score of 20.89, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score20.89